NASDAQ:ADUS - Addus HomeCare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $107.60
  • Forecasted Upside: 27.16 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$84.62
▲ +1.34 (1.61%)

This chart shows the closing price for ADUS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Addus HomeCare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ADUS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ADUS

Analyst Price Target is $107.60
▲ +27.16% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Addus HomeCare in the last 3 months. The average price target is $107.60, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 27.16% upside from the last price of $84.62.

This chart shows the closing price for ADUS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Addus HomeCare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/28/2022Stifel NicolausInitiated CoverageBuy$101.00Low
6/21/2022StephensLower Price TargetOverweight$110.00 ➝ $101.00Low
5/4/2022Royal Bank of CanadaLower Price Target$125.00 ➝ $111.00High
4/13/2022Bank of AmericaInitiated CoverageBuy$110.00Medium
3/10/2022Royal Bank of CanadaBoost Price TargetOutperform$124.00 ➝ $125.00Low
11/3/2021Royal Bank of CanadaLower Price TargetOutperform$137.00 ➝ $124.00High
8/4/2021Raymond JamesLower Price TargetOutperform$125.00 ➝ $115.00High
10/1/2020OppenheimerReiterated RatingBuyHigh
8/12/2020BMO Capital MarketsBoost Price Target$103.00 ➝ $115.00High
8/11/2020OppenheimerBoost Price TargetOutperform$107.00 ➝ $115.00High
6/17/2020Robert W. BairdBoost Price TargetOutperform$96.00 ➝ $100.00Medium
6/1/2020SidotiBoost Price TargetBuy$96.00 ➝ $115.00Low
5/6/2020Robert W. BairdBoost Price TargetOutperform$80.00 ➝ $96.00Low
5/4/2020OppenheimerReiterated RatingBuy$107.00High
4/20/2020Royal Bank of CanadaReiterated RatingBuy$98.00Low
3/18/2020SidotiLower Price TargetBuy$115.00 ➝ $96.00High
12/10/2019OppenheimerBoost Price Target$96.00 ➝ $107.00Low
11/6/2019Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$90.00 ➝ $100.00Low
11/6/2019Raymond JamesBoost Price TargetOutperform$92.00 ➝ $95.00Medium
10/21/2019StephensInitiated CoverageOverweight$97.00Low
9/17/2019OppenheimerSet Price TargetBuy$91.00Low
8/21/2019SidotiSet Price TargetBuy$115.00N/A
8/9/2019William BlairReiterated RatingOutperformHigh
8/7/2019BMO Capital MarketsSet Price TargetHold$85.00Medium
8/7/2019OppenheimerBoost Price TargetBuy$80.00 ➝ $91.00Low
8/7/2019Raymond JamesSet Price TargetOutperform$81.00 ➝ $92.00Medium
8/6/2019SidotiBoost Price TargetBuy$84.00 ➝ $96.00Medium
6/27/2019BMO Capital MarketsInitiated CoverageMarket Perform ➝ Market PerformLow
6/13/2019Raymond JamesBoost Price TargetOutperform$75.00 ➝ $81.00High
2/4/2019Robert W. BairdUpgradeNeutral ➝ Outperform$72.00 ➝ $75.00High
11/7/2018OppenheimerBoost Price TargetOutperform$72.00 ➝ $80.00Low
10/8/2018Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$81.00Medium
9/12/2018Cantor FitzgeraldInitiated CoverageOverweight$77.00Low
8/21/2018Jefferies Financial GroupInitiated CoverageBuy$75.00 ➝ $75.00Low
8/20/2018Raymond JamesInitiated CoverageOutperform$75.00Low
8/8/2018OppenheimerBoost Price TargetOutperform$50.00 ➝ $72.00Low
8/8/2018Robert W. BairdReiterated RatingHold$65.00Low
8/7/2018StephensBoost Price TargetOverweight$67.00 ➝ $75.00High
4/2/2018StephensSet Price TargetBuy$56.00Medium
3/14/2018Robert W. BairdSet Price TargetHold$43.00Low
9/19/2017OppenheimerReiterated RatingBuy$45.00Low
8/29/2017OppenheimerReiterated RatingBuy$45.00Medium
8/24/2017Robert W. BairdReiterated RatingHold$40.00Medium
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/6/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/5/2022
  • 6 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/7/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/6/2022
  • 6 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/6/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/5/2022
  • 2 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 2 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Addus HomeCare logo
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Read More

Today's Range

Now: $84.62
Low: $81.05
High: $84.80

50 Day Range

MA: $82.24
Low: $75.30
High: $87.03

52 Week Range

Now: $84.62
Low: $68.57
High: $108.11

Volume

6,203 shs

Average Volume

80,010 shs

Market Capitalization

$1.36 billion

P/E Ratio

30.44

Dividend Yield

N/A

Beta

0.83

Frequently Asked Questions

What sell-side analysts currently cover shares of Addus HomeCare?

The following equities research analysts have issued reports on Addus HomeCare in the last twelve months: Bank of America Co., Raymond James, Royal Bank of Canada, Stephens, Stifel Nicolaus, StockNews.com, and TheStreet.
View the latest analyst ratings for ADUS.

What is the current price target for Addus HomeCare?

0 Wall Street analysts have set twelve-month price targets for Addus HomeCare in the last year. Their average twelve-month price target is $107.60, suggesting a possible upside of 27.2%.
View the latest price targets for ADUS.

What is the current consensus analyst rating for Addus HomeCare?

Addus HomeCare currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ADUS will outperform the market and that investors should add to their positions of Addus HomeCare.
View the latest ratings for ADUS.

What other companies compete with Addus HomeCare?

How do I contact Addus HomeCare's investor relations team?

Addus HomeCare's physical mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company's listed phone number is (469) 535-8200 and its investor relations email address is [email protected] The official website for Addus HomeCare is www.addus.com. Learn More about contacing Addus HomeCare investor relations.